rs633903

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000459.5(TEK):​c.1625-1194T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.199 in 152,194 control chromosomes in the GnomAD database, including 3,426 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.20 ( 3426 hom., cov: 32)

Consequence

TEK
NM_000459.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.232

Publications

13 publications found
Variant links:
Genes affected
TEK (HGNC:11724): (TEK receptor tyrosine kinase) This gene encodes a receptor that belongs to the protein tyrosine kinase Tie2 family. The encoded protein possesses a unique extracellular region that contains two immunoglobulin-like domains, three epidermal growth factor (EGF)-like domains and three fibronectin type III repeats. The ligand angiopoietin-1 binds to this receptor and mediates a signaling pathway that functions in embryonic vascular development. Mutations in this gene are associated with inherited venous malformations of the skin and mucous membranes. Alternative splicing results in multiple transcript variants. Additional alternatively spliced transcript variants of this gene have been described, but their full-length nature is not known. [provided by RefSeq, Feb 2014]
TEK Gene-Disease associations (from GenCC):
  • multiple cutaneous and mucosal venous malformations
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, Labcorp Genetics (formerly Invitae), G2P, PanelApp Australia
  • primary congenital glaucoma
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • TEK-related primary glaucoma
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • glaucoma 3, primary congenital, E
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia
  • congenital glaucoma
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.25 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000459.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TEK
NM_000459.5
MANE Select
c.1625-1194T>G
intron
N/ANP_000450.3Q02763-1
TEK
NM_001375475.1
c.1625-1194T>G
intron
N/ANP_001362404.1
TEK
NM_001290077.2
c.1496-1194T>G
intron
N/ANP_001277006.2Q02763-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TEK
ENST00000380036.10
TSL:1 MANE Select
c.1625-1194T>G
intron
N/AENSP00000369375.4Q02763-1
TEK
ENST00000519080.1
TSL:1
c.1055-1194T>G
intron
N/AENSP00000428337.1E5RIV9
TEK
ENST00000923267.1
c.1667-1194T>G
intron
N/AENSP00000593326.1

Frequencies

GnomAD3 genomes
AF:
0.199
AC:
30239
AN:
152076
Hom.:
3428
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.109
Gnomad AMI
AF:
0.326
Gnomad AMR
AF:
0.148
Gnomad ASJ
AF:
0.165
Gnomad EAS
AF:
0.117
Gnomad SAS
AF:
0.178
Gnomad FIN
AF:
0.328
Gnomad MID
AF:
0.161
Gnomad NFE
AF:
0.253
Gnomad OTH
AF:
0.185
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.199
AC:
30240
AN:
152194
Hom.:
3426
Cov.:
32
AF XY:
0.200
AC XY:
14850
AN XY:
74392
show subpopulations
African (AFR)
AF:
0.109
AC:
4521
AN:
41552
American (AMR)
AF:
0.147
AC:
2256
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.165
AC:
572
AN:
3472
East Asian (EAS)
AF:
0.117
AC:
607
AN:
5178
South Asian (SAS)
AF:
0.178
AC:
859
AN:
4824
European-Finnish (FIN)
AF:
0.328
AC:
3472
AN:
10582
Middle Eastern (MID)
AF:
0.160
AC:
47
AN:
294
European-Non Finnish (NFE)
AF:
0.253
AC:
17221
AN:
67966
Other (OTH)
AF:
0.184
AC:
388
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1201
2401
3602
4802
6003
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
318
636
954
1272
1590
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.222
Hom.:
2868
Bravo
AF:
0.182
Asia WGS
AF:
0.151
AC:
527
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
1.1
DANN
Benign
0.74
PhyloP100
-0.23
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs633903; hg19: chr9-27196119; COSMIC: COSV66228265; COSMIC: COSV66228265; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.